Accessing leading pediatric
eczema research

Pedskin offers screening opportunities for children with atopic dermatitis in Miami, Florida.

Check if your child qualifies.
IRB approved
No Cost to Participate

“When your child’s skin won’t stop itching, everything else suffers.”

Sleepless nights, constant discomfort, and persistent irritation are just a few of the challenges that come with atopic dermatitis (Eczema).

But eczema isn’t just about dry skin; it can significantly impact your child’s mood, confidence, sleep, and even your entire family’s daily life.

If your child is struggling with eczema, you may be eligible to participate in a clinical research study that’s exploring new treatment options specifically designed for children.

What does your family receive?

A specialized program

Access to board-certified pediatric specialist in skin conditions

Keep on Track

Close care and monitoring from specialist throughout the study

Reimbursements

Compensation for your time and reasonable travel expenses.

Check Eligibility

Unlock answers for their unique skin

The Atopic Dermatitis Study (Protocol INC 18424-312) is not a general eczema study. This is along-term clinical research study for children with moderate to severe atopiz dermatitis, it is designed for children who still struggle despite previous treatments, it focus on long-term control, not just short-term relief and includes continous monitoring by pediatric specialists.

Parents should understand this study is nor starting from zero, rather it builds on prior treatment phases and evaluates ongoing management of eczema, not just initial response.

Parents begin by submitting a short eligibility form. A research coordinator then contacts them to explain the study and complete the screening process, including consent. If the child qualifies, they are enrolled and start the study treatment.

Throughout the study, the child attends scheduled visits for monitoring, skin assessments, and progress tracking, while following simple at-home instructions. At the end, a final evaluation and safety follow-up are completed. Participation is voluntary, and families may withdraw at any time.

Your privacy is important to us. Any information you provide through this website or during the eligibility screening process will be kept strictly confidential and used only for the purpose of evaluating potential participation in this research study.

Your child’s personal and medical information will be handled in accordance with applicable privacy laws and research regulations. Submitting your information does not obligate you to participate in the study.

Does your child meet the basic criteria?

Children may be eligible if they meet the following general conditions. A study team member will review your child’s full history during the screening process.

Basic eligibility criteria

Age 1 to 12 years old

Children under 12 years old at the time of enrollment

Moderate to severe dermatitis

Patient has moderate to severe atopic dermatitis

Previous treatment

Patient has participated in previous treatment or has ongoing symptoms

Can attend regular visits

The study requires regular visits over several months.

What happens if we enroll?

1

Pre-screening

Complete a short form to see whether your child may be eligible based on basic criteria. No medical records needed at this stage.

2

Screening visit

If the pre-screen looks promising, you’ll meet with the study team in person. They’ll review your child’s history, examine the affected areas, and answer every question you have before any decisions are made.

3

Participation (if eligible)

Enrolled participants will receive study treatment and continue basic skincare (like moisturizers) as instructed. Initial visits at week 2 and week 4. Then visits approximately every 4 weeks. Some visits may be done from home depending on stage.

4

Study Completion & Safety Monitoring

Treatment may last up to 12 months. The study team will walk you through what happens after the study ends, including next steps for your child’s ongoing care.

Why participate in a research study?

Clinical research plays a crucial role in providing children with access to new treatments and advancing medical knowledge for future generations. Our mission is to create new opportunities for children and families by advancing research and ensuring that they have access to innovative therapies that have the potential to transform lives.

Dr. Mercedes E. González

Pediatric Dermatology Specialist & Principal Investigator

We are here to provide clarity.

Safety is the study’s top priority. The investigational medication has been studied in adults and is now being evaluated in adolescents. Your teen will be closely monitored with regular bloodwork, vital signs, and clinical assessments. An independent safety committee also reviews data continuously throughout the study.

Families are free to withdraw from the study at any time without consequence. Participation is entirely voluntary.

There is no cost to participate. Study medication, clinic visits, and all study-related lab work are provided at no charge. Participants may also receive compensation for time and travel — please speak with our team for details.

After completing the open-label extension, participants finish a 4-week follow-up visit. Our team will discuss ongoing care options at that time. Data collected will help advance treatment options for adolescents with alopecia areata.

Your teen may qualify for this study.

If your child has severe alopecia areata and is between the ages of 12 and 17, find out in less than 2 minutes whether they may be eligible to participate at no cost to your family.

Check Eligibility Now →

It only takes 20 seconds.

© 2026 PEDSKIN Research
All rights reserved

This is a research facility. Treatments are investigational.
Participation is voluntary.